Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; rehabilitation tools that displays and tracks upper-extremity rehabilitation exercises under the REAL Immersive System brand name; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names...
Website: penumbrainc.com



Growth: Good revenue growth rate 17.9%, there is acceleration compared to average historical growth rates 17.3%. The revenue growth dynamics is stable Site traffic for the last 3 months showed a change of -4.2%

Profitability: LTM EBITDA margin is positive, +14.2%. On average the margin is improving unsteadily. Gross margin is high, +67.8%. In the last quarter the company beat the estimated EPS, +109.1%. The company was ahead of estimated EPS in 80% of quarters (showing a gain of +$0.02 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 0.4% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 119.4% higher than minimum and 0.1% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 3.1x by EV / Sales multiple , the company can be 70.5% overvalued

Insiders: For the last 3 months insiders sold company shares on $10.0 mln (-0.085% of cap.)

Key Financials (Download financials)

Ticker: PEN
Share price, USD:  (0.0%)359
year average price 277.58  


year start price 268.67 2025-02-14

min close price 225.54 2025-11-05

max close price 359.26 2026-01-23

current price 359.00 2026-02-13
Common stocks: 39 078 378

Dividend Yield:  0.0%
FCF Yield LTM: 0.4%
EV / LTM EBITDA: 73.7x
EV / EBITDA annualized: 74.1x
Last revenue growth (y/y):  +17.9%
Last growth of EBITDA (y/y):  +38.2%
Historical revenue growth:  +17.3%
Historical growth of EBITDA:  +114.8%
EV / Sales: 10.4x
Margin (EBITDA LTM / Revenue): 14.2%
Fundamental value created in LTM:
Market Cap ($m): 14 029
Net Debt ($m): -104
EV (Enterprise Value): 13 925
Price to Book: 10.3x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-01-27globenewswire.com

Halper Sadeh LLC Encourages PEN and RAPT Shareholders to Contact the Firm to Discuss Their Rights

2026-01-16prnewswire.com

Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN

2026-01-16zacks.com

Penumbra (PEN) Moves 11.8% Higher: Will This Strength Last?

2026-01-15prnewswire.com

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Penumbra, Inc. (NYSE: PEN)

2026-01-15barrons.com

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion.

2026-01-15marketwatch.com

Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing' vascular segments

2026-01-15reuters.com

Boston Scientific to buy Penumbra in deal valued at $14.5 billion

2026-01-13seekingalpha.com

Penumbra, Inc. (PEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-12zacks.com

Why Penumbra (PEN) is a Top Momentum Stock for the Long-Term

2025-11-18zacks.com

Why Penumbra (PEN) is a Top Momentum Stock for the Long-Term
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol PEN PEN PEN PEN PEN PEN PEN PEN PEN PEN PEN PEN PEN PEN
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-05 2025-07-29 2024-10-30 2024-07-30 2024-05-07 2023-11-02 2023-08-01 2023-05-02 2022-11-03
acceptedDate 2025-11-05 16:44:08 2025-07-29 16:53:53 2025-02-18 16:44:59 2024-10-30 16:47:14 2024-07-30 16:45:20 2024-05-07 16:44:56 2024-02-22 16:46:55 2023-11-02 16:57:38 2023-08-01 16:44:47 2023-05-02 16:44:54 2023-02-23 16:45:50 2022-11-03 16:45:41 2022-02-22 16:47:02 2021-02-23 17:17:25
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 355M 339M 1 195M 301M 299M 279M 1 059M 271M 261M 241M 847M 214M 748M 560M
costOfRevenue 114M 115M 440M 101M 139M 100M 376M 93M 95M 90M 312M 78M 272M 222M
grossProfit 240M 224M 755M 200M 160M 179M 683M 178M 167M 151M 535M 135M 475M 338M
grossProfitRatio 0.678 0.66 0.665 0.536 0.641 0.656 0.638 0.626 0.633
researchAndDevelopmentExpenses 23M 23M 95M 25M 25M 25M 84M 21M 22M 20M 79M 21M 105M 90M
generalAndAdministrativeExpenses 0 0 572M 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 2M 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 169M 160M 574M 140M 139M 142M 506M 126M 127M 123M 450M 109M 378M 287M
otherExpenses 0 0 77M 0 -226 000 0 18M -444 000 808 000 90 000 0 0 0 0
operatingExpenses 192M 183M 746M 165M 164M 167M 609M 147M 149M 143M 529M 130M 483M 377M
costAndExpenses 306M 299M 1 185M 266M 303M 267M 985M 240M 244M 233M 841M 208M 755M 599M
interestIncome 4M 4M 14M 3M 4M 0 7M 1M 0 0 2M 0 3M 1M
interestExpense 338 000 319 000 1M 336 000 344 000 0 2M 1M 839 000 554 000 2M -43 000 2M 0
depreciationAndAmortization 2M 6M 24M 4M 8M 8M 27M 7M 7M 7M 24M 4M 16M 13M
ebitda 55M 51M 46M 44M -70M 20M 109M 56M 18M 8M 30M 9M 8M -26M
ebitdaratio 0.155 0.151 0.147 0.012 0.07 0.207 0.068 0.033 0.043
operatingIncome 49M 41M 9M 35M -4M 12M 74M 13M 18M 1M 6M 5M -8M -39M
operatingIncomeRatio 0.138 0.12 0.117 -0.013 0.043 0.047 0.068 0.006 0.025
totalOtherIncomeExpensesNet 3M 4M 12M 4M 3M 3M 6M -19M 808 000 7M -2M -2M -3M 924 000
incomeBeforeTax 52M 45M 21M 40M -78M 15M 80M 13M 20M 9M 4M 3M -11M -38M
incomeBeforeTaxRatio 0.148 0.133 0.132 -0.26 0.052 0.049 0.075 0.036 0.014
incomeTaxExpense 6M 40 000 7M 10M -18M 4M -11M 4M 576 000 90 000 6M 5M -13M -19M
netIncome 46M 45M 14M 30M -60M 11M 91M 9M 19M 9M -2M -2M 5M -16M
netIncomeRatio 0.129 0.133 0.098 -0.201 0.039 0.034 0.073 0.035 -0.011
eps 1.17 1.17 0.36 0.76 -1.55 0.28 2.37 0.24 0.49 0.22 -0.053 -0.06 0.071 -0.54
epsdiluted 1.17 1.15 0.75 -1.55 0.28 0.23 0.48 0.22 -0.06
weightedAverageShsOut 39M 39M 39M 39M 39M 39M 38M 38M 38M 38M 38M 38M 37M 36M
weightedAverageShsOutDil 39M 39M 39M 39M 39M 39M 39M 39M 39M 39M 38M 38M 38M 36M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-18 2024-02-22 2023-02-23 2022-02-22 2021-02-23
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 12M 5M 137 000 938 000 1M
ebit 22M 81M 6M -9M -39M
nonOperatingIncomeExcludingInterest -13M -8M 441 000 1M 0
netIncomeFromContinuingOperations 14M 91M -2M 3M -19M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 14M 91M -2M 5M -16M
epsDiluted 0.36 2.32 -0.053 0.069 -0.54

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol PEN PEN PEN PEN PEN PEN PEN PEN PEN PEN PEN PEN PEN PEN
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-05 2025-07-29 2024-10-30 2024-07-30 2024-05-07 2023-11-02 2023-08-01 2023-05-02 2022-11-03
acceptedDate 2025-11-05 16:44:08 2025-07-29 16:53:53 2025-02-18 16:44:59 2024-10-30 16:47:14 2024-07-30 16:45:20 2024-05-07 16:44:56 2024-02-22 16:46:55 2023-11-02 16:57:38 2023-08-01 16:44:47 2023-05-02 16:44:54 2023-02-23 16:45:50 2022-11-03 16:45:41 2022-02-22 16:47:02 2021-02-23 17:17:25
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 321M 422M 324M 280M 288M 223M 167M 101M 114M 95M 70M 55M 59M 70M
shortTermInvestments 149M 3M 16M 11M 51M 90M 122M 148M 107M 104M 118M 130M 195M 195M
cashAndShortTermInvestments 470M 425M 340M 291M 340M 313M 289M 249M 221M 199M 188M 184M 255M 265M
netReceivables 183M 176M 168M 176M 201M 192M 202M 207M 209M 207M 203M 189M 134M 115M
inventory 432M 428M 407M 393M 374M 398M 388M 374M 359M 344M 334M 320M 264M 220M
otherCurrentAssets 55M 38M 37M 31M 29M 31M 36M 39M 39M 36M 30M 30M 0 0
totalCurrentAssets 1 142M 1 065M 951M 892M 944M 935M 915M 868M 828M 786M 756M 724M 681M 618M
propertyPlantEquipmentNet 295M 286M 268M 270M 270M 292M 281M 282M 285M 288M 280M 273M 227M 127M
goodwill 167M 167M 166M 166M 166M 166M 166M 166M 166M 166M 166M 165M 166M 8M
intangibleAssets 6M 7M 7M 7M 7M 68M 83M 73M 76M 79M 92M 83M 91M 11M
goodwillAndIntangibleAssets 173M 173M 172M 173M 173M 235M 249M 239M 242M 245M 258M 249M 257M 19M
longTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
taxAssets 94M 109M 0 106M 109M 85M 85M 64M 67M 65M 64M 63M 66M 50M
otherNonCurrentAssets 40M 40M 141M 39M 39M 34M 26M 15M 11M 11M 13M 13M 13M 9M
totalNonCurrentAssets 603M 609M 582M 587M 591M 645M 641M 600M 605M 609M 615M 598M 563M 205M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 1 744M 1 675M 1 533M 1 479M 1 535M 1 580M 1 556M 1 468M 1 433M 1 395M 1 371M 1 322M 1 244M 823M
accountPayables 30M 28M 31M 33M 33M 32M 27M 28M 26M 28M 27M 25M 13M 14M
shortTermDebt 16M 15M 0 29M 28M 14M 0 13M 13M 12M 0 11M 0 0
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 1M 5M 9M 7M 8M 8M 9M 9M 10M 0 0
otherCurrentLiabilities 124M 114M 112M 112M 85M 98M 0 96M 97M 97M 0 92M 0 10M
totalCurrentLiabilities 170M 158M 158M 153M 151M 153M 151M 145M 144M 146M 145M 138M 123M 106M
longTermDebt 202M 205M 0 212M 215M 218M 0 216M 219M 221M 0 206M 0 0
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 5M
otherNonCurrentLiabilities 15M 18M 15M 9M 8M 6M 5M 3M 3M 3M 3M 163M 4M 3M
totalNonCurrentLiabilities 216M 223M 224M 222M 222M 224M 226M 219M 222M 225M 227M 210M 167M 79M
otherLiabilities 0 0 0 0 1 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 202M 221M 223M 227M 229M 218M 234M 229M 231M 234M 236M 218M 174M 77M
totalLiabilities 386M 381M 382M 375M 373M 376M 377M 364M 366M 371M 372M 348M 290M 185M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 39 000 39 000 38 000 38 000 39 000 39 000 39 000 38 000 38 000 38 000 38 000 38 000 37 000 36 000
retainedEarnings 190M 144M 60M 26M 86M 146M 135M 81M 71M 52M 44M 40M 46M 41M
accumulatedOtherComprehensiveIncomeLoss 3M 3M -6M -963 000 -5M -5M -3M -7M -6M -7M -8M -13M -3M 3M
othertotalStockholdersEquity 1 165M 1 146M 1 079M 1 081M 1 062M 1 031M 1 001M 979M 947M
totalStockholdersEquity 1 359M 1 294M 1 151M 1 104M 1 161M 1 204M 1 179M 1 104M 1 067M 1 024M 999M 974M 954M 641M
totalEquity 1 359M 1 294M 1 151M 1 104M 1 161M 1 204M 1 179M 1 104M 1 067M 1 024M 999M 974M 954M 638M
totalLiabilitiesAndStockholdersEquity 1 744M 1 675M 1 479M 1 535M 1 580M 1 468M 1 433M 1 395M 1 322M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 -4M
totalLiabilitiesAndTotalEquity 1 744M 1 675M 1 533M 1 479M 1 535M 1 580M 1 556M 1 468M 1 433M 1 395M 1 371M 1 322M 1 244M 823M
totalInvestments 149M 3M 16M 11M 51M 90M 122M 148M 107M 104M 118M 130M 195M 195M
totalDebt 217M 221M 223M 227M 229M 231M 234M 229M 231M 234M 236M 218M 174M 77M
netDebt -104M -201M -101M -54M -60M 8M 67M 128M 117M 139M 166M 163M 114M 8M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-18 2024-02-22 2023-02-23 2022-02-22 2021-02-23
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 168M 202M 203M 134M 115M
otherReceivables 0 0 0 0 0
prepaids 0 0 0 29M 19M
totalPayables 31M 27M 27M 13M 14M
otherPayables 0 0 0 0 0
accruedExpenses 0 104M 97M 100M 76M
capitalLeaseObligationsCurrent 15M 13M 12M 10M 6M
capitalLeaseObligationsNonCurrent 209M 221M 224M 164M 71M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 1 097M 1 047M 963M 911M 598M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol PEN PEN PEN PEN PEN PEN PEN PEN PEN PEN PEN PEN PEN PEN
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-05 2025-07-29 2024-10-30 2024-07-30 2024-05-07 2023-11-02 2023-08-01 2023-05-02 2022-11-03
acceptedDate 2025-11-05 16:44:08 2025-07-29 16:53:53 2025-02-18 16:44:59 2024-10-30 16:47:14 2024-07-30 16:45:20 2024-05-07 16:44:56 2024-02-22 16:46:55 2023-11-02 16:57:38 2023-08-01 16:44:47 2023-05-02 16:44:54 2023-02-23 16:45:50 2022-11-03 16:45:41 2022-02-22 16:47:02 2021-02-23 17:17:25
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 46M 45M 14M 30M -60M 11M 91M 9M 19M 9M -2M -2M 5M -19M
depreciationAndAmortization 2M 6M 24M 4M 8M 8M 31M 7M 7M 7M 28M 6M 19M 13M
deferredIncomeTax 15M -7M -16M 3M -24M 475 000 -19M 2M -1M -953 000 1M 6M -14M -19M
stockBasedCompensation 16M 14M 46M 11M 10M 14M 0 14M 13M 13M 0 10M 0 26M
changeInWorkingCapital -22M -14M -24M 4M -24M 6M -79M -23M -24M -15M -122M -34M -67M -51M
accountsReceivables -8M -5M 27M 25M -10M 8M -266 000 2M -5M -4M -70M -3M -21M -8M
inventory -4M -11M -66M 64M -11M -12M -68M -21M -15M -11M -75M -26M -52M -57M
accountsPayables 2M -3M 4M 543 000 283 000 5M 1M 2M -2M 2M 13M 4M -2M -308 000
otherWorkingCapital -12M 5M 11M -86M -2M 4M -12M -6M -1M -3M 10M -9M 8M 14M
otherNonCashItems 1M 966 000 125M 5M 160M 27M 74M 21M 4M 1M 39M 2M 66M 18M
netCashProvidedByOperatingActivities 58M 45M 168M 56M 23M 38M 97M 31M 17M 13M -56M -13M 10M -33M
investmentsInPropertyPlantAndEquipment -16M -16M -21M -5M -5M -6M -15M -3M -4M -4M -19M -6M -21M -25M
acquisitionsNet 0 0 0 0 0 0 -988 000 -988 000 0 0 0 0 3M 0
purchasesOfInvestments -147M -1000 -33M -2M -41 000 -21M -82M -58M 0 0 0 0 -127M -153M
salesMaturitiesOfInvestments 0 0 131M 43M 40M 43M 83M 18M 13M 15M 74M 16M 124M 77M
otherInvestingActivites 0 0 0 -500 000 2M -988 000 -16M 0 0
netCashUsedForInvestingActivites -163M -16M 36M 34M 18M -44M -7M 11M 10M
debtRepayment -612 000 -691 000 -578 000 -559 000 -550 000 -499 000 -483 000 -474 000 -441 000
commonStockIssued 5M 16M -299 000 0 238 000 834 000 0 2M 0
commonStockRepurchased 0 0 -100M -100M -89 000 -421 000 0 -123 000 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites -90 000 -62 000 -100M 9M -482 000 711 000 9M -359 000 -162 000
netCashUsedProvidedByFinancingActivities 4M 15M -101M 8M -794 000 212 000 9M 1M -603 000
effectOfForexChangesOnCash -91 000 2M -2M 510 000 -141 000 -257 000 168 000 -70 000 357 000 -386 000 -272 000 336 000 1M -635 000
netChangeInCash -101M 46M 157M -8M 65M 56M 98M -13M 19M 25M 10M -3M -10M -3M
cashAtEndOfPeriod 321M 422M 324M 280M 288M 223M 167M 101M 114M 95M 70M 55M 59M 70M
cashAtBeginningOfPeriod 422M 376M 167M 288M 223M 167M 70M 114M 95M 70M 59M 58M 70M 73M
operatingCashFlow 58M 45M 168M 56M 23M 38M 97M 31M 17M 13M -56M -13M 10M -33M
capitalExpenditure -16M -16M -21M -5M -5M -6M -15M -3M -4M -4M -19M -6M -21M -25M
freeCashFlow 42M 29M 147M 51M 18M 32M 82M 28M 13M 9M -75M -19M -12M -58M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-18 2024-02-22 2023-02-23 2022-02-22 2021-02-23
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 1M -500 000 0 -400 000 -3M
netCashProvidedByInvestingActivities 78M -16M 55M -22M -104M
netDebtIssuance -2M -2M -2M -1M -3M
longTermNetDebtIssuance -2M -2M -2M -1M -3M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance -100M 20M 22M 18M 135M
netCommonStockIssuance -100M 20M 22M 18M 135M
commonStockIssuance 0 20M 22M 18M 135M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 16M -2M -8M -16M 4M
netCashProvidedByFinancingActivities -87M 16M 12M 836 000 135M
incomeTaxesPaid 21M 0 0 0 1M
interestPaid 0 0 0 0 0

Earning call transcript

2025 q3
2025-11-05 ET (fiscal 2025 q3)
2025 q2
2025-07-29 ET (fiscal 2025 q2)
2025 q1
2025-04-23 ET (fiscal 2025 q1)
2024 q4
2025-02-18 ET (fiscal 2024 q4)
2024 q3
2024-10-30 ET (fiscal 2024 q3)
2024 q2
2024-07-30 ET (fiscal 2024 q2)
2024 q1
2024-05-07 ET (fiscal 2024 q1)
2023 q4
2024-02-22 ET (fiscal 2023 q4)
2023 q3
2023-11-02 ET (fiscal 2023 q3)
2023 q2
2023-08-01 ET (fiscal 2023 q2)
2023 q1
2023-05-02 ET (fiscal 2023 q1)
2022 q4
2023-02-23 ET (fiscal 2022 q4)
2022 q3
2022-11-06 ET (fiscal 2022 q3)
2022 q2
2022-08-07 ET (fiscal 2022 q2)
2022 q1
2022-05-03 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-11-05 21:44 ET
Penumbra reported for 2025 q3
SEC form 8
2025-11-05 21:15 ET
Penumbra published news for 2025 q3
SEC form 8
2025-11-05 21:15 ET
Penumbra reported for 2025 q3
SEC form 10
2025-07-29 20:53 ET
Penumbra reported for 2025 q2
SEC form 8
2025-07-29 20:14 ET
Penumbra reported for 2025 q2
SEC form 8
2025-07-29 20:14 ET
Penumbra published news for 2025 q2
SEC form 10
2025-04-23 20:44 ET
Penumbra published news for 2025 q1
SEC form 8
2025-04-23 20:14 ET
Penumbra reported for 2025 q1
SEC form 8
2025-04-23 20:14 ET
Penumbra published news for 2025 q1
SEC form 10
2025-04-23 00:00 ET
Penumbra published news for 2025 q1
SEC form 10
2025-02-18 21:44 ET
Penumbra published news for 2024 q4
SEC form 10
2025-02-18 00:00 ET
Penumbra published news for 2024 q4
SEC form 8
2025-02-18 00:00 ET
Penumbra reported for 2024 q4
SEC form 8
2025-02-18 00:00 ET
Penumbra published news for 2024 q4
SEC form 10
2024-10-30 16:47 ET
Penumbra reported for 2024 q3
SEC form 8
2024-10-30 16:14 ET
Penumbra reported for 2024 q3
SEC form 8
2024-10-30 16:14 ET
Penumbra published news for 2024 q3
SEC form 10
2024-10-30 00:00 ET
Penumbra reported for 2024 q3
SEC form 10
2024-07-30 16:45 ET
Penumbra published news for 2024 q2
SEC form 8
2024-07-30 16:15 ET
Penumbra reported for 2024 q2
SEC form 8
2024-07-30 16:15 ET
Penumbra published news for 2024 q2
SEC form 10
2024-07-30 00:00 ET
Penumbra published news for 2024 q2
SEC form 10
2024-05-07 16:44 ET
Penumbra published news for 2024 q1
SEC form 8
2024-05-07 16:14 ET
Penumbra reported for 2024 q1
SEC form 8
2024-05-07 16:14 ET
Penumbra published news for 2024 q1
SEC form 10
2024-05-07 00:00 ET
Penumbra published news for 2024 q1
SEC form 10
2024-02-22 16:46 ET
Penumbra published news for 2023 q4
SEC form 8
2024-02-22 16:14 ET
Penumbra reported for 2023 q4
SEC form 8
2024-02-22 16:14 ET
Penumbra published news for 2023 q4
SEC form 10
2024-02-22 00:00 ET
Penumbra published news for 2023 q4
SEC form 10
2023-11-02 16:57 ET
Penumbra published news for 2023 q3
SEC form 8
2023-11-02 16:14 ET
Penumbra reported for 2023 q3
SEC form 10
2023-11-02 00:00 ET
Penumbra published news for 2023 q3
SEC form 10
2023-08-01 16:44 ET
Penumbra reported for 2023 q2
SEC form 6
2023-08-01 16:14 ET
Penumbra published news for 2023 q2
SEC form 8
2023-08-01 00:00 ET
Penumbra published news for 2023 q2
SEC form 10
2023-08-01 00:00 ET
Penumbra published news for 2023 q2
SEC form 6
2023-06-02 17:03 ET
Penumbra published news for 2023 q1
SEC form 10
2023-05-02 00:00 ET
Penumbra published news for 2023 q1
SEC form 8
2023-05-02 00:00 ET
Penumbra reported for 2023 q1
SEC form 10
2023-02-23 16:45 ET
Penumbra reported for 2022 q4
SEC form 6
2023-02-23 16:15 ET
Penumbra published news for 2022 q4
SEC form 8
2023-02-23 00:00 ET
Penumbra reported for 2022 q4
SEC form 10
2023-02-23 00:00 ET
Penumbra reported for 2022 q4
SEC form 10
2022-11-03 16:45 ET
Penumbra reported for 2022 q3
SEC form 6
2022-11-03 16:16 ET
Penumbra published news for 2022 q3
SEC form 10
2022-11-03 00:00 ET
Penumbra reported for 2022 q3
SEC form 8
2022-11-03 00:00 ET
Penumbra reported for 2022 q3
SEC form 6
2022-08-05 16:20 ET
Penumbra published news for 2022 q2
SEC form 10
2022-08-05 00:00 ET
Penumbra reported for 2022 q2
SEC form 8
2022-08-05 00:00 ET
Penumbra reported for 2022 q2
SEC form 6
2022-08-04 21:38 ET
Penumbra published news for 2022 q2
SEC form 10
2022-08-04 20:42 ET
Penumbra reported for 2022 q2
SEC form 6
2022-06-07 16:36 ET
Penumbra published news for 2022 q1
SEC form 10
2022-05-03 16:50 ET
Penumbra reported for 2022 q1
SEC form 6
2022-05-03 16:13 ET
Penumbra published news for 2022 q1
SEC form 10
2022-05-03 00:00 ET
Penumbra reported for 2022 q1
SEC form 8
2022-05-03 00:00 ET
Penumbra reported for 2022 q1
SEC form 6
2022-04-20 16:34 ET
Penumbra published news for 2022 q1
SEC form 6
2022-04-08 16:22 ET
Penumbra published news for 2022 q1
SEC form 10
2022-02-22 16:47 ET
Penumbra published news for 2021 q4
SEC form 6
2022-02-22 16:15 ET
Penumbra published news for 2021 q4
SEC form 8
2022-02-22 00:00 ET
Penumbra published news for 2021 q4
SEC form 10
2022-02-22 00:00 ET
Penumbra published news for 2021 q4
SEC form 6
2022-01-10 06:03 ET
Penumbra published news for 2021 q4
SEC form 10
2021-11-03 16:45 ET
Penumbra published news for 2021 q3
SEC form 6
2021-11-03 16:13 ET
Penumbra published news for 2021 q3
SEC form 10
2021-11-03 00:00 ET
Penumbra published news for 2021 q3
SEC form 8
2021-11-03 00:00 ET
Penumbra published news for 2021 q3
SEC form 6
2021-10-07 16:38 ET
Penumbra published news for 2021 q3
SEC form 6
2021-09-22 17:09 ET
Penumbra published news for 2021 q2
SEC form 10
2021-08-09 16:31 ET
Penumbra published news for 2021 q2
SEC form 6
2021-08-09 16:15 ET
Penumbra published news for 2021 q2
SEC form 8
2021-08-09 00:00 ET
Penumbra published news for 2021 q2
SEC form 10
2021-08-09 00:00 ET
Penumbra published news for 2021 q2
SEC form 6
2021-06-08 16:04 ET
Penumbra published news for 2021 q1
SEC form 10
2021-05-04 16:45 ET
Penumbra published news for 2021 q1
SEC form 6
2021-05-04 16:16 ET
Penumbra published news for 2021 q1
SEC form 8
2021-05-04 00:00 ET
Penumbra published news for 2021 q1
SEC form 10
2021-05-04 00:00 ET
Penumbra published news for 2021 q1
SEC form 6
2021-04-22 17:03 ET
Penumbra published news for 2021 q1
SEC form 10
2021-02-23 17:17 ET
Penumbra published news for 2020 q4
SEC form 6
2021-02-23 16:10 ET
Penumbra published news for 2020 q4
SEC form 6
2021-01-11 08:00 ET
Penumbra published news for 2020 q4
SEC form 6
2020-12-15 16:26 ET
Penumbra published news for 2020 q3
SEC form 6
2020-12-08 15:50 ET
Penumbra published news for 2020 q3
SEC form 6
2020-12-07 08:01 ET
Penumbra published news for 2020 q3
SEC form 10
2020-11-02 17:08 ET
Penumbra published news for 2020 q3
SEC form 6
2020-10-28 16:15 ET
Penumbra published news for 2020 q3